Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xylo Technologies Ltd (XYLO)
NASDAQ:XYLO
Holding XYLO?
Track your performance easily
XYLO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.50 - $4.88
Previous Close$1.86
Volume8.47K
Average Volume (3M)76.15K
Market Cap
$3.47M
Enterprise Value$12.75M
Total Cash (Recent Filing)$9.37M
Total Debt (Recent Filing)$9.79M
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Sep 02, 2024EPS EstimateN/A
Last Dividend Ex-Date
Dec 19, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-9.62
Shares Outstanding1,865,964
10 Day Avg. Volume16,984
30 Day Avg. Volume76,146
Standard Deviation0.25
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.12
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.84
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xylo Technologies Ltd News
PremiumCompany Announcements
Xylo Technologies Offers Pre-Funded Warrant for ADSs
PremiumCompany Announcements
Xylo Technologies Gains Shareholder Approval at AGM
PremiumCompany Announcements
Xylo Technologies Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
Xylo Technologies Reports Decreased Assets and LiabilitiesPremiumCompany Announcements
Xylo’s ParaZero Boosts Medical Delivery with Drone Safety Tech
PremiumCompany Announcements
Xylo Technologies Unveils Sustainable Urban Cargo Bike
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XYLO FAQ
What was Xylo Technologies Ltd’s price range in the past 12 months?
Xylo Technologies Ltd lowest stock price was $1.50 and its highest was $4.88 in the past 12 months.
What is Xylo Technologies Ltd’s market cap?
Currently, no data Available
When is Xylo Technologies Ltd’s upcoming earnings report date?
Xylo Technologies Ltd’s upcoming earnings report date is Sep 02, 2024 which is 81 days ago.
How were Xylo Technologies Ltd’s earnings last quarter?
Xylo Technologies Ltd released its earnings results on May 01, 2024. The company reported -$4.596 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.596.
Is Xylo Technologies Ltd overvalued?
According to Wall Street analysts Xylo Technologies Ltd’s price is currently Overvalued.
Does Xylo Technologies Ltd pay dividends?
Xylo Technologies Ltd pays a Notavailable dividend of $0.8 which represents an annual dividend yield of N/A. See more information on Xylo Technologies Ltd dividends here
What is Xylo Technologies Ltd’s EPS estimate?
Xylo Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xylo Technologies Ltd have?
Xylo Technologies Ltd has 1,701,638 shares outstanding.
What happened to Xylo Technologies Ltd’s price movement after its last earnings report?
Xylo Technologies Ltd reported an EPS of -$4.596 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.5%.
Which hedge fund is a major shareholder of Xylo Technologies Ltd?
Currently, no hedge funds are holding shares in XYLO
---
Xylo Technologies Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.29%
12-Months-Change
Fundamentals
Return on Equity
-51.74%
Trailing 12-Months
Asset Growth
-34.57%
Trailing 12-Months
Company Description
Xylo Technologies Ltd
Medigus Ltd. is a medical device company, which engages in the research and development, manufacture, and sale of endosurgical tools and instruments. It specializes in the area of Gastroesophageal reflux disease. Its product MUSE System offers minimal invasive endoscopic devices and procedures for gastric surgery. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel.
---
Technical Analysis
---